Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 04 Feb 2025

Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity

in Cancer Immunity and Immunotherapy

Eduardo López-Collazo
Laura Hurtado-Navarro

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524781

566 views

Correction

Published on 04 Feb 2025

Corrigendum: A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection

in Cancer Immunity and Immunotherapy

Ping Li
Ziyi Jiang
Jingjing Shi
Haochuan Sha
Zihang Yu
Yan Zhao
Sanyang Han
Lan Ma

Frontiers in Immunology

doi 10.3389/fimmu.2025.1559927

340 views

Clinical Trial

Published on 04 Feb 2025

Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma

in Cancer Immunity and Immunotherapy

Yuan Yao
Yiyi Yan
Vera J. Suman
Allan B. Dietz
Courtney L. Erskine
Anastasios Dimou
Svetomir N. Markovic
Robert R. McWilliams
Heather N. Montane
Matthew S. Block

Frontiers in Immunology

doi 10.3389/fimmu.2025.1491448

573 views

Systematic Review

Published on 04 Feb 2025

Prognostic value of systemic immune-inflammation index for patients undergoing radical prostatectomy: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Zhan Chen
Yao Zhang
Wei Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1465971

358 views

Original Research

Published on 04 Feb 2025

Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective cohort study

in Cancer Immunity and Immunotherapy

Zhouwei Zhan
Bijuan Chen
Shaohua Xu
Ruyu Lin
Haiting Chen
Xiaohuan Ma
Xuanping Lin
Wanting Huang
Changhua Zhuo
Yu Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1518217

530 views

Original Research

Published on 04 Feb 2025

Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer

in Cancer Immunity and Immunotherapy

Qiying Song
Shihe Liu
Di Wu
Aizhen Cai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1511453

462 views

Original Research

Accepted on 03 Feb 2025

Zinc finger protein ZC3H18 is abnormally expressed in esophageal cancer tissues and facilitates the proliferation of esophageal cancer cells

in Cancer Immunity and Immunotherapy

Yujin Zhang#
Yilong Wan
Jiaxi Li
Sheng Ju
Xin Tong
Ji Wu
Hao Wu
Liuqing Zhang
Shengxiang Shao
Yuhong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1556509

Editorial

Published on 03 Feb 2025

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens

in Cancer Immunity and Immunotherapy

Parham Jabbarzadeh Kaboli
Charalampos Proestos

Frontiers in Immunology

doi 10.3389/fimmu.2025.1560135

421 views

Original Research

Published on 03 Feb 2025

The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression

in Cancer Immunity and Immunotherapy

Yige Zhao
Yong Li
Panpan Wang
Mengyan Zhu
Jiaqi Wang
Bo Xie
Chenyu Tang
Yangyang Ma
Shiwen Wang
Sha Jin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474564

693 views

Review

Published on 03 Feb 2025

Insights into CSF-1/CSF-1R signaling: the role of macrophage in radiotherapy

in Cancer Immunity and Immunotherapy

Qingchao Shang
Pei Zhang
Xiao Lei
Lehui Du
Baolin Qu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1530890

345 views

Original Research

Published on 03 Feb 2025

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma

in Cancer Immunity and Immunotherapy

Laura M. Moser
Catrin Heim
Sebastian E. Koschade
Philipp Wendel
Süleyman Bozkurt
Sabine Harenkamp
Hermann Kreyenberg
Michael Merker
Christian Münch
Elise Gradhand

Frontiers in Immunology

doi 10.3389/fimmu.2025.1485817

1,001 views

Original Research

Published on 03 Feb 2025

Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy

in Cancer Immunity and Immunotherapy

Nan Zhang
Shiyun Chen
Yue Shi
Zhikuan Wang
Ru Jia
Guanghai Dai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1487318

495 views

Original Research

Published on 03 Feb 2025

Assessment of prognosis and responsiveness to immunotherapy in colorectal cancer patients based on the level of immune cell infiltration

in Cancer Immunity and Immunotherapy

Kaili Liao
Minqi Zhu
Lei Guo
Zijun Gao
Jinting Cheng
Bing Sun
Yihui Qian
Bingying Lin
Jingyan Zhang
Tingyi Qian

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514238

530 views

Original Research

Published on 03 Feb 2025

Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1/JNK/c-Jun signaling

in Cancer Immunity and Immunotherapy

Bisha Ding
Jie Li
Jia-Lin Yan
Chun-Yan Jiang
Ling-Bo Qian
Jie Pan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1515605

532 views

Original Research

Published on 03 Feb 2025

An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis

in Cancer Immunity and Immunotherapy

Xiaolu Yang
Yilun Li
Yaqi Peng
Yuan Chang
Binglu He
Tianqi Zhang
Shiyu Zhang
Cuizhi Geng
Yunjiang Liu
Xiaolong Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546794

576 views

Study Protocol

Accepted on 31 Jan 2025

Nab-Paclitaxel Combined with Cadonilimab (AK104) as Second-Line Treatment for Advanced Gastric Cancer: Protocol for a Phase II Prospective, Multicenter, Single-Arm Clinical Trial

in Cancer Immunity and Immunotherapy

Jing Wei
Qiancheng Hu
Xiaolong Cheng
Chaoyong Shen
Zhixin Chen
Wen Zhuang
Yuan Yin
Bo Zhang
HongFeng Gou
Kun Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519545

Navigation group

Articles

Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity

Corrigendum: A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection

Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma

Prognostic value of systemic immune-inflammation index for patients undergoing radical prostatectomy: a systematic review and meta-analysis

Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective cohort study

Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer

Zinc finger protein ZC3H18 is abnormally expressed in esophageal cancer tissues and facilitates the proliferation of esophageal cancer cells

Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens

The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression

Insights into CSF-1/CSF-1R signaling: the role of macrophage in radiotherapy

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma

Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy

Assessment of prognosis and responsiveness to immunotherapy in colorectal cancer patients based on the level of immune cell infiltration

Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1/JNK/c-Jun signaling

An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis

Nab-Paclitaxel Combined with Cadonilimab (AK104) as Second-Line Treatment for Advanced Gastric Cancer: Protocol for a Phase II Prospective, Multicenter, Single-Arm Clinical Trial